title: Mass spectrometric determination of early and advanced glycation in biology.
abstract: Protein glycation in biological systems occurs predominantly on lysine, arginine and N-terminal residues of proteins. Major quantitative glycation adducts are found at mean extents of modification of 1-5 mol percent of proteins. These are glucose-derived fructosamine on lysine and N-terminal residues of proteins, methylglyoxal-derived hydroimidazolone on arginine residues and N(ε)-carboxymethyl-lysine residues mainly formed by the oxidative degradation of fructosamine. Total glycation adducts of different types are quantified by stable isotopic dilution analysis liquid chromatography-tandem mass spectrometry (LC-MS/MS) in multiple reaction monitoring mode. Metabolism of glycated proteins is followed by LC-MS/MS of glycation free adducts as minor components of the amino acid metabolome. Glycated proteins and sites of modification within them - amino acid residues modified by the glycating agent moiety - are identified and quantified by label-free and stable isotope labelling with amino acids in cell culture (SILAC) high resolution mass spectrometry. Sites of glycation by glucose and methylglyoxal in selected proteins are listed. Key issues in applying proteomics techniques to analysis of glycated proteins are: (i) avoiding compromise of analysis by formation, loss and relocation of glycation adducts in pre-analytic processing; (ii) specificity of immunoaffinity enrichment procedures, (iii) maximizing protein sequence coverage in mass spectrometric analysis for detection of glycation sites, and (iv) development of bioinformatics tools for prediction of protein glycation sites. Protein glycation studies have important applications in biology, ageing and translational medicine - particularly on studies of obesity, diabetes, cardiovascular disease, renal failure, neurological disorders and cancer. Mass spectrometric analysis of glycated proteins has yet to find widespread use clinically. Future use in health screening, disease diagnosis and therapeutic monitoring, and drug and functional food development is expected. A protocol for high resolution mass spectrometry proteomics of glycated proteins is given.
authors.affiliation: Warwick Systems Biology Centre, Senate House, University of Warwick, Coventry, CV4 7AL, UK. N.Rabbani@warwick.ac.uk.
authors.forename: Naila
authors.initials: N
authors.lastname: Rabbani
authors.affiliation: Clinical Sciences Research Laboratories, Warwick Medical School, University Hospital, University of Warwick, Coventry, CV2 2DX, UK.
authors.forename: Amal
authors.initials: A
authors.lastname: Ashour
authors.affiliation: Warwick Systems Biology Centre, Senate House, University of Warwick, Coventry, CV4 7AL, UK.|Clinical Sciences Research Laboratories, Warwick Medical School, University Hospital, University of Warwick, Coventry, CV2 2DX, UK.
authors.forename: Paul J
authors.initials: PJ
authors.lastname: Thornalley
mesh_terms: D000818:Animals; D002853:Chromatography, Liquid / Q000379:methods; D017127:Glycation End Products, Advanced / Q000032:analysis*; D006801:Humans; D013058:Mass Spectrometry / Q000379:methods*
chemical_list: D017127:Glycation End Products, Advanced
keywords: Bioinformatics; Glucose; Glycation; Hydroimidazolone; Mass spectrometry; Methylglyoxal, fructosamine; Orbitrap; Proteomics